RBA Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
RBA Wealth Management's ABBV Position: Q3 2026 in Review
RBA Wealth Management opened a new position in AbbVie (ABBV) in Q3 2026: 949 shares worth $248K. The stake represents 0.08% of the portfolio and ranks #100 among its holdings. This is a return to the name: RBA Wealth Management previously reported a position in ABBV as recently as Q1 2023.
RBA Wealth Management first reported a position in ABBV in Q2 2020 and has held it in 13 quarters since. The position peaked at $3.53M in Q4 2022. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- RBA Wealth Management held 949 shares of AbbVie worth $248K as of Q3 2026.
- AbbVie was a new RBA Wealth Management position in Q3 2026.
- AbbVie made up 0.08% of RBA Wealth Management's portfolio in Q3 2026, its #100 holding.
- RBA Wealth Management first reported a position in AbbVie in Q2 2020 and has held it in 13 quarters since.
- RBA Wealth Management's AbbVie position peaked at $3.53M in Q4 2022.
- 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on RBA Wealth Management's 13F filing for Q3 2026, filed 28 Oct 2026.